![](https://investorshub.advfn.com/uicon/520574.png?cb=1465937687)
Monday, February 05, 2024 10:20:53 AM
VG Life Sciences, Inc.
447 Broadway, 2nd Floor
Unit 103
New York, NY 10013
February 5, 2024 - Supplemental Information Disclosure for VG Life Sciences, Inc. (the
“Company”):
The Company has nominated William P. Farrand as Director, President & Chief Executive
Officer of the Company.
The Company has Amended and Restated its Articles of Incorporation with the Florida Secretary
of State.
The Company’s new official Twitter [X] account is @VGLSIR
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM